The global market for Marine Biotechnology was valued at an estimated US$7.3 Billion in 2023 and is projected to reach US$13.1 Billion by 2030, growing at a CAGR of 8.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the marine biotechnology market is driven by several factors, including advancements in genomics and molecular biology, increasing demand for natural products, and the expanding scope of marine-derived compounds in various industries. Technological progress in DNA sequencing and bioinformatics has significantly enhanced our ability to explore and exploit marine biodiversity, leading to the discovery of novel bioactive molecules and pathways.
The rising consumer preference for natural and sustainable products in pharmaceuticals and cosmetics fuels the demand for marine-sourced ingredients. Additionally, the urgent need for sustainable solutions in energy and environmental management propels the development and adoption of marine biotechnology innovations. Government initiatives and funding aimed at promoting marine research and biotechnological applications further support market growth. The confluence of these factors ensures that marine biotechnology will continue to expand, driving both scientific discovery and commercial development in the years to come.
The growth in the marine biotechnology market is driven by several factors, including advancements in genomics and molecular biology, increasing demand for natural products, and the expanding scope of marine-derived compounds in various industries. Technological progress in DNA sequencing and bioinformatics has significantly enhanced our ability to explore and exploit marine biodiversity, leading to the discovery of novel bioactive molecules and pathways.
The rising consumer preference for natural and sustainable products in pharmaceuticals and cosmetics fuels the demand for marine-sourced ingredients. Additionally, the urgent need for sustainable solutions in energy and environmental management propels the development and adoption of marine biotechnology innovations. Government initiatives and funding aimed at promoting marine research and biotechnological applications further support market growth. The confluence of these factors ensures that marine biotechnology will continue to expand, driving both scientific discovery and commercial development in the years to come.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Biomaterials segment, which is expected to reach US$6.6 Billion by 2030 with a CAGR of a 9.4%. The Bioactive Substances segment is also set to grow at 8.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.1 Billion in 2023, and China, forecasted to grow at an impressive 12.4% CAGR to reach $1.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Marine Biotechnology Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Marine Biotechnology Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Marine Biotechnology Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Aker BioMarine AS, Aqua Bio Technology ASA, BASF SE, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 230 Featured):
- Aker BioMarine AS
- Aqua Bio Technology ASA
- BASF SE
- CP Kelco U.S., Inc.
- Cyanotech Corp.
- GlycoMar Ltd.
- Marinova Pty Ltd
- Nutrex Hawaii Inc.,
- oceanBASIS GmbH
- PharmaMar S.A
- Royal DSM N.V
- SEPPIC
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISFRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAAUSTRALIAINDIASOUTH KOREAREST OF ASIA-PACIFICIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
REST OF EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aker BioMarine AS
- Aqua Bio Technology ASA
- BASF SE
- CP Kelco U.S., Inc.
- Cyanotech Corp.
- GlycoMar Ltd.
- Marinova Pty Ltd
- Nutrex Hawaii Inc.,
- oceanBASIS GmbH
- PharmaMar S.A
- Royal DSM N.V
- SEPPIC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 786 |
| Published | July 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 7.3 Billion |
| Forecasted Market Value ( USD | $ 13.1 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
